CompletedNCT02613494
Glycopyrrolate or Hyoscine for Clozapine-Related Drooling
About this title
Read the official source — NCT02613494Medication studyAges 18–65United KingdomSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Preston and 1 more locationSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateStarted: January 25, 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 29
- Sponsor
- Mersey Care NHS Trust
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United Kingdom
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02613494
- Official title
Show the full official title
A Feasibility Study of Glycopyrrolate in Comparison to Hyoscine Hydrobromide and Placebo in the Treatment of Hypersalivation Induced by Clozapine
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Preston · Liverpool
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Mersey Care NHS Trust, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Hyoscine and Glycopyrrolate.
Who was this study for?
Listed age limits: 18 years to 65 years.
